Skip to main content
AI Market Summary
Loading market intelligence...

GenMark Diagnostics Inc (GNMK) Stock Forecast 2025 - AI Price Prediction & Analysis


GenMark Diagnostics Inc (GNMK) AI Stock Price Forecast & Investment Analysis

GenMark Diagnostics Inc Stock Price Chart and Technical Analysis

Loading GenMark Diagnostics Inc interactive price chart and technical analysis...

GenMark Diagnostics Inc (GNMK) - Comprehensive Stock Analysis & Investment Research

Deep dive into GenMark Diagnostics Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about GenMark Diagnostics Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For GenMark Diagnostics Inc: GenMark Diagnostics Inc operates in the Manufacturing sector, making it an emerging small-cap investment.

GenMark Diagnostics Inc (Stock Symbol: GNMK) is a leading company in the Manufacturing sector , specifically operating within the Surgical and Medical Instrument Manufacturing industry.

The organization employs approximately 437 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing GenMark Diagnostics Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For GenMark Diagnostics Inc: With $172M in annual revenue and -10.9% net margin, the company demonstrates developing profitability.

Annual Revenue: $172 million generating a -10.9% net profit margin .

Market Capitalization: $1635 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -35.1% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for GenMark Diagnostics Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For GenMark Diagnostics Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for GenMark Diagnostics Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: GenMark Diagnostics Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For GenMark Diagnostics Inc: Market positioning analysis based on available financial and operational metrics.

GenMark Diagnostics Inc strategically competes in the highly dynamic Surgical and Medical Instrument Manufacturing marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 39.6% gross margin, indicating strong pricing power and operational efficiency.

GenMark Diagnostics Inc (GNMK) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for GenMark Diagnostics Inc stock analysis.

Loading GenMark Diagnostics Inc comprehensive fundamental analysis and insider trading data...

Deep dive into GenMark Diagnostics Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if GenMark Diagnostics Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For GenMark Diagnostics Inc: With a P/E ratio of -85.86, the market sees the stock as potentially undervalued.

P/E Ratio -85.86x
P/B Ratio 18.78x
Market Cap $1635M
EPS $-0.28
Book Value/Share $1.28
Revenue/Share $2.53
FCF/Share $-0.18
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently GenMark Diagnostics Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For GenMark Diagnostics Inc: An ROE of -35.1% indicates room for improvement in shareholder value creation.

ROE -35.1%
ROA -11.1%
ROIC -9.7%
Gross Margin 39.6%
Operating Margin -6.4%
Net Margin -10.9%
EBT Margin -10.8%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess GenMark Diagnostics Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For GenMark Diagnostics Inc: A current ratio of 3.92 indicates strong liquidity.

Current Ratio 3.92x
Quick Ratio 3.38x
D/E Ratio 0.89x
Financial Leverage 2.37x
Interest Coverage -1.4x
Working Capital $129M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal GenMark Diagnostics Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For GenMark Diagnostics Inc: Free cash flow of $-12M indicates cash challenges that need attention.

Operating Cash Flow $6M
Free Cash Flow $-12M
Capital Spending $-18M
FCF/Sales -6.8%
CapEx/Sales 10.4%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively GenMark Diagnostics Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For GenMark Diagnostics Inc: An asset turnover of 1.02x demonstrates efficient asset utilization.

Asset Turnover 1.02x
Receivables Turnover 9.1x
Inventory Turnover 6.4x
Fixed Assets Turnover 4.8x
Days Sales Outstanding 40 days
Days Inventory 57 days
Payables Period 62 days
Cash Conversion Cycle 35 days
Understanding Financial Statement Data

What these metrics mean: Key figures from GenMark Diagnostics Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For GenMark Diagnostics Inc: With annual revenue of $172M, GenMark Diagnostics Inc demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $172M
Operating Income $-11M
Net Income $-19M
R&D Expense $18M
SG&A Expense $28M
Cost of Goods Sold $60M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 77%
Cash & Short-term Investments 57%
Total Liabilities 58%
Short-term Debt 7%
Accounts Receivable 9%
Inventory 10%
Dividend & Shareholder Information
Shares Outstanding 68M

Latest GenMark Diagnostics Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting GenMark Diagnostics Inc (GNMK) stock price and investment outlook.

, source: Business Wire

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today reported second quarter 2015 ...

, source: Insider Monkey

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have gone over 821 13F ...

GenMark Diagnostics Inc Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of GenMark Diagnostics Inc against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - GenMark Diagnostics Inc Stock Forecast

How accurate are GenMark Diagnostics Inc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for GNMK predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence GenMark Diagnostics Inc stock price forecasts?

Our analysis considers GenMark Diagnostics Inc's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is GenMark Diagnostics Inc a good investment in 2025?

Based on our AI analysis, GenMark Diagnostics Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are GenMark Diagnostics Inc forecasts updated?

GenMark Diagnostics Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced GenMark Diagnostics Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for GenMark Diagnostics Inc stock.

My Portfolio

Investment Dashboard

Loading your portfolio...